Notably, SETD2 knockout (KO) ccRCC-derived 786-0 cells, previously generated and described in more detail [19], showed a significantly higher proliferation rate than their SETD2 proficient (+/+) counterparts (Supplementary Figure 1). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.